BDBM50040751 CHEMBL351938::[(4S,7S,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid
SMILES CC(=O)N[C@@H]1CSSC(C)(C)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](CCCNC(N)=N)NC1=O)C(N)=O
InChI Key InChIKey=FWEONMXPHGWDHS-IATRGZMQSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 50040751
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Affinity DataKi: 720nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Affinity DataKi: >1.00E+6nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair